- Not determined .

|                        | PKC isoform   | PKC isoform   | PKC isoform   | PKC isoform   | PKC isoform   | PKC isoform   | PKC isoform   | PKC isoform   | PKC isoform   |           |           |
|------------------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|-----------|-----------|
| Cell line              |               | BI/BII        |               |               |               |               |               |               |               | Detection | Reference |
| WMI15 (primary)        |               | ND            | ND            | ND            | ND            | ND            | ND            | ND            | ND            | W         | [36]      |
| WMI2O5Lu (metastatic)  |               | ND            | ND            | ND            | ND            | ND            | ND            |               | ND            | W         | [36]      |
| SK-Mel 28 (metastatic) |               |               |               | +             |               | ND            |               |               | ND            |           | [29]      |
| A375 (primary)         |               |               |               |               |               | ND            | +             | +             | ND            | WR        | [29]      |
| Murine                 |               |               |               |               |               |               |               |               |               |           |           |
| B16 (metastatic)       |               |               | +             | ND            | ND            | ND            | ND            | ND            | ND            |           | [37]      |
| B16-Fl (metastatic)    |               | ND            | ND            | ND            |               |               |               |               |               |           | [38]      |
|                        |               |               |               | +             |               |               |               |               |               |           |           |
| B16 (metastatic)       | 1             | ND            | ND            | ND            | ND            |               |               | ND            | ND            |           | [40]      |
| B16 (metastatic)       |               | ND            | ND            |               | "             | ND            | ND            | ND            | ND            |           | {42]      |
| B16 (metastatic)       |               |               |               |               |               | +             |               | ND            | ND            |           | [43]      |
| B16 (metastatic)       |               |               |               |               |               |               | ND            | 4             | ND            |           | [44]      |
| B16-BL6 (metastatic)   |               | ND            | ND            | ND            |               | ND            | ND            | ND            | ND            |           | [45]      |
| B16-BL6 (metastatic)   | ND            | ND            | ND            |               | ND            | ND            | ND            | ND            | ND            |           | [46]      |

- Not determined.

the B isoform in melanocytes [49], and further showed murine skin in vivo [50]. It is interesting to assume that the rosinase activity; but melanin is detected even in the melanoma cells lacking the PKC B isoform [25,27]. On the other hand, the œ isoform is increased in murine and the induction as well as the overexpression of this

PKC isoform enhances the melanin synthesis; suggest the involvement of the œ isoform in melanogenesis [38]. The level of the & isoform is also elevated in B16 a novel extracellular glycolipid from that induces differ entiation of HL-60 promyelocytic leukemia cells [44]. The introduction of antisense oligodeoxynucleotides against the prevented mannosylerythiritol ing yeast

Table 3.

|            | PKC isoform    | PKC isoform   | PKC isoform   | PKC isoform   | PKC isoform   | PKC isoform   | PKC isoform   | PKC isoform   | PKC isoform   |    |             |           |
|------------|----------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|----|-------------|-----------|
| Origin     | Clinical type* |               | BI/BII        | Y             | 8             |               |               |               |               |    | Detection** | Reference |
| Primary    | ALM            | +             |               |               | +             | +             | ND***         | ND            | +             | ND | W           | [25]      |
| Metastatic | Unknown        |               |               |               |               |               | ND            | ND            | +             | ND | W           | [25]      |
| Metastatic | NS (5 cases)   | ND            | +             | ND            |               |               | ND            | ND            | ND            | ND |             | [27]      |
| Metastatic | NS (5 cases)   | ND            |               | ND            | ND            | ND            | ND            | ND            | ND            | ND |             |           |
| Metastatic | SSM            | + +           |               |               |               |               |               |               |               |    |             | [28]      |
| Metastatic | NS (5 cases)   |               |               |               |               |               |               |               | +             |    |             | [28]      |
| Metastatic | ALM 2cases)    |               |               |               |               |               |               |               |               |    | "           | [28]      |
| Primary    | ALM            |               | ND            | ND            | ND            | ND            | ND            | ND            | ND            | ND |             | [36]      |
| Primary    | ALM cases) (11 | +             |               | ND            | ND            | ND            | ND            | ND            | ND            | ND |             | [36]      |
| Primary    | cases)         |               |               | ND            |               | ND            | ND            | ND            | ND            | ND |             | [36]      |
| Metastatic | ALM (2 cases)  | +             | ND            | ND            | ND            | ND            | ND            | ND            | ND            | ND |             | [36]      |
| Metastatic | SSM (2 cases)  |               | ND            | ND            |               | ND            | ND            | ND            | ND            | ND |             | [36]      |

- ALM: acral lentiginous melanoma: SSM: superficial spreading melanoma; NS: not stated.
- k